Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

NM Red River shooting
George Maharis dies
Makeup criticized
NK infant jailed
Captured & euthanized
1500 arrested in NL
Indo-Pacific deal
Claps back at critics
Shatters own record
Largest drone attack
National Hamburger Day
Nun's uncorrupted body
Unveils new parliament
Horse fatality tragedy
Defends debt deal
CA no home insurance
Bakhmut attacks eased
Regulation initiative
Pentecost celebration
Turkish vision clash
Border water tensions
Plane exit violation
Lukashenko in hospital
Heatwave claims lives
Justice amidst control
2023 Indianapolis 500
New IL state budget
First domestic plane
Chad Pinder to retire
WWE NXT Battleground
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
20,100 results
5don MSN
FDA approves prescription nasal spray to reverse opioid overdoses
The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee ...
WTVF26d
FDA approves first over-the-counter naloxone nasal spray
NASHVILLE, Tenn. (WTVF) — The FDA recently approved an over-the-counter naloxone nasal spray. The medication, known as Narcan, reverses the effects of an opioid overdose. Advocates say it's a ...
drugdeliverybusiness5d
FDA approves another nasal spray for treating opioid overdose
The FDA approved Opvee nalmefene hydrochloride nasal spray for the emergency treatment of opioid overdoses from Opiant ...
Medscape2d
FDA Approvals
FDA Approves Methylphenidate Patch for Teens With ADHD The FDA has approved an expanded age range for a methylphenidate transdermal system for the treatment of ADHD in adolescents aged 13 to 17 years.
Seeking Alpha17d
Emergent BioSolutions: A Turnaround In Sight With OTC Narcan Amidst Ongoing Opioid Crisis
The FDA has approved Emergent's over-the-counter Narcan, a drug to treat opioid overdoses. OTC Narcan can contribute significantly to combatting the escalating opioid crisis in the U.S. The OTC ...
AOL4d
Here's why parents should have Narcan, the drug that reverses an opioid overdose, at home: 'This is a lifesaving medication'
In an effort to reduce the rising number of opioid overdoses in the U.S., including from fentanyl, the Food and Drug Administration (FDA) in March approved the first over-the-counter Narcan nasal ...
EdSource2d
FDA approves Pfizer vaccine for children ages 12 to 15
The Food and Drug Administration authorized the emergency use of its Pfizer-BioNTech vaccine for adolescents age 12 to 15 today, according to the New York Times. Authorization is given for the ...
5d
FDA Approves New Nasal Spray to Reverse Opioid Overdoses
It’s not yet clear how the drug will be used differently than naloxone, and some experts see downsides to its longer-acting ...
FOX 10 Phoenix
5d
FDA approves new nasal spray to reverse fentanyl, other opioid overdoses
U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl ...
EMS1
5d
FDA approves new nasal spray to reverse fentanyl, opioid overdoses
U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl ...
Too Old to Operate
4d
FDA Approves New Nasal Spray to Reverse Overdoses
The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as Opvee, the spray contains the medication nalmefene hydrochloride and will ...
High Times
4d
FDA Approves Nasal Spray To Reverse Fentanyl Overdoses
The Food and Drug Administration on Monday said that it had given regulatory approval to a nasal spray that has proven ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics

opioid overdose
Opvee
Food and Drug Administration
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback